Key facts
- This page summarizes Arthur A. Torres's Form 4/A filing for CareDx, Inc. (CDNA).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 20 Jun 2024, 16:46.
Arthur A. Torres - 14 Jun 2024 Form 4/A Insider Report for CareDx, Inc. (CDNA)
- Reporting relationship
- Director
- Issuer ticker
- CDNA
- Reported as of
- 14 Jun 2024
- Net transaction value
- $0
- SEC form
- 4/A
- Accepted by SEC
- 20 Jun 2024, 16:46:47 UTC
- Original report date
- 18 Jun 2024
- Prior SEC filing
- 21 Jun 2023
- Next SEC filing
- 17 Jun 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Arthur Torres
Source evidence
Original filing metadata and source links for verification.
6 source fields
Reporting owner
1 detail
Filing notes and source
Key filing fact
Arthur A. Torres filed Form 4/A for CareDx, Inc. (CDNA) on 20 Jun 2024.
Change
- Previous filing in this sequence was filed on 21 Jun 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4/A disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CDNA
transaction
Derivative
Stock Option (right to buy)
Award
- Transaction value
- $0
- Shares
- +16,048
- Change %
- Price
- $0.000000
- Shares after
- 16,048
- Date
- 14 Jun 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 16,048
- Exercise price
- $14.19
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
This amendment is being filed to correct the exercise price of the derivative security of the Stock Option (right to buy) reported on the original Form 4.
Footnote F2
1/12th of the shares subject to this option shall vest on July 14, 2024, and 1/12th of the shares subject to the option shall vest monthly thereafter through June 14, 2025.